Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation in secondary stroke and systemic embolism prevention

BACKGROUND: Oral anticoagulants (OAC) are recommended in all patients with atrial fibrillation (AF) after thromboembolic events without contraindications. It is hypothesized herein, that the majority of patients with AF after thromboembolic events receive OAC and the presence of specific factors, pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorczyca, Iwona, Michalska, Anna, Chrapek, Magdalena, Jelonek, Olga, Wałek, Paweł, Wożakowska-Kapłon, Beata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2019
Materias:
Clinical Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747826/
https://www.ncbi.nlm.nih.gov/pubmed/31313276
http://dx.doi.org/10.5603/CJ.a2019.0069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747826/
https://www.ncbi.nlm.nih.gov/pubmed/31313276
http://dx.doi.org/10.5603/CJ.a2019.0069

Ejemplares similares